Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-17

Clinical Trial Update: Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902) [Phase 4]

View source ↗

Summary

Phase 4 trial update on revaccination with PNEUMOVAX 23 in older Japanese adults; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infection | Phase 4 | Status: COMPLETED | Results posted: 2016-02-17